NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/19/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
SYSTEMETRIC
ST13
US500000079149152Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Current location
Holders
Representatives
Jeffrey A. Smith Millen White Zelano and Branigan
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
[ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
Class 9
[ Scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; Laboratory apparatus and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes ]
Class 42
Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services [ and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect, [ and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] pharmaceutical research and development; Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
History of USPTO decisions and trademark events.
49 publications found
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/19/2026
REGISTERED-SEC.71 ACCEPTED
05/19/2026
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/18/2026
TEAS SECTION 71 RECEIVED
01/20/2026
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
07/21/2024
INTERNATIONAL REGISTRATION RENEWED
04/04/2024
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/07/2023
PARTIAL INVALIDATION PROCESSED BY THE IB
03/28/2023
LIMITATION OF GOODS RECEIVED FROM IB
03/27/2023
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/22/2023
INVALIDATION PROCESSED
02/22/2023
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/01/2023
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/01/2022
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
05/01/2022
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2022
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/16/2022
TEAS SECTION 71 & 15 RECEIVED
07/21/2021
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/21/2020
FINAL DECISION TRANSACTION PROCESSED BY IB
01/04/2016
FINAL DISPOSITION NOTICE SENT TO IB
12/02/2015
FINAL DISPOSITION PROCESSED
12/02/2015
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/21/2015
REGISTERED-PRINCIPAL REGISTER
07/21/2015
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2015
PUBLISHED FOR OPPOSITION
05/05/2015
NOTIFICATION PROCESSED BY IB
05/02/2015
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2015
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/15/2015
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2015
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/27/2015
ASSIGNED TO LIE
03/27/2015
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2015
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2015
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2015
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2015
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/23/2014
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/23/2014
REFUSAL PROCESSED BY IB
09/11/2014
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/26/2014
REFUSAL PROCESSED BY MPU
08/26/2014
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/26/2014
NON-FINAL ACTION WRITTEN
08/25/2014
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
08/25/2014
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/22/2014
NON-FINAL ACTION WRITTEN
08/21/2014
ASSIGNED TO EXAMINER
08/13/2014
APPLICATION FILING RECEIPT MAILED
08/02/2014
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2014
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/19/2014
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.